Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-Risk Neuroblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06013618
What this trial is testing

Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma

Who this might be right for
Neuroblastoma
Sun Yat-Sen University Cancer Center 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT05421897
What this trial is testing

Rapid Administration Pilot for Infusing Dinutuximab

Who this might be right for
Neuroblastoma
Children's Hospital Los Angeles 30
Testing effectiveness (Phase 2)Ended earlyNCT01440283
What this trial is testing

A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) in High Risk Abdominal Neuroblastoma

Who this might be right for
Abdominal Neuroblastoma
St. Jude Children's Research Hospital 14
Not applicableEnrolling By InvitationNCT07595666
What this trial is testing

Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.

Who this might be right for
DementiaMovement DisordersALS - Amyotrophic Lateral Sclerosis+11 more
prof. dr. Koen Van Laere 1,600
Not applicableStudy completedNCT01510600
What this trial is testing

Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Oncology Group 99
Large-scale testing (Phase 3)Looking for participantsNCT07375563
What this trial is testing

Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma

Who this might be right for
Neuroblastoma (NB)Ganglioneuroblastoma
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 5
Testing effectiveness (Phase 2)Ended earlyNCT03165292
What this trial is testing

Evaluation of 2 Intensification Treatment Strategies for Neuroblastoma Patients With a Poor Response to Induction

Who this might be right for
Very High Risk Neuroblastoma
Gustave Roussy, Cancer Campus, Grand Paris 34
Early research (Phase 1)Study completedNCT00885326
What this trial is testing

N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 29
Early research (Phase 1)Study completedNCT01208454
What this trial is testing

Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma

Who this might be right for
Localized Unresectable NeuroblastomaRecurrent NeuroblastomaRegional Neuroblastoma+2 more
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Study completedNCT00053326
What this trial is testing

Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma

Who this might be right for
Recurrent Neuroblastoma
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Study completedNCT03033303
What this trial is testing

The Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 59
Early research (Phase 1)Study completedNCT00084422
What this trial is testing

N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 47
Testing effectiveness (Phase 2)Study completedNCT00923351
What this trial is testing

Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma

Who this might be right for
NeuroblastomaSarcomaRhabdomyosarcoma-Embryonal+2 more
National Cancer Institute (NCI) 44
Early research (Phase 1)Study completedNCT00450307
What this trial is testing

Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 32
Early research (Phase 1)Study completedNCT00638898
What this trial is testing

Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor

Who this might be right for
Solid TumorAdult Central Nervous System Germ Cell TumorAdult Rhabdomyosarcoma+27 more
City of Hope Medical Center 25
Testing effectiveness (Phase 2)Looking for participantsNCT06803875
What this trial is testing

Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaHigh-risk Neuroblastoma
Roberto Chiarle 42
Testing effectiveness (Phase 2)Study completedNCT01183416
What this trial is testing

High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Myeloablative Therapy and Autologous Stem-Cell Transplantation

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 4
Early research (Phase 1)Study completedNCT02076906
What this trial is testing

MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors

Who this might be right for
Relapsed Pediatric Solid TumorsRefractory Pediatric Solid TumorsRhabdomyosarcoma+7 more
AeRang Kim 7
Early research (Phase 1)Study completedNCT00005835
What this trial is testing

N99-02: Melphalan and Buthionine Sulfoximine

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 31
Testing effectiveness (Phase 2)Ended earlyNCT01183884
What this trial is testing

3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 46
Next Page